{"id":2466,"date":"2019-11-07T15:38:27","date_gmt":"2019-11-07T15:38:27","guid":{"rendered":"https:\/\/plaza.umin.ac.jp\/~ACP\/?page_id=2466"},"modified":"2019-11-07T15:38:27","modified_gmt":"2019-11-07T15:38:27","slug":"%e8%a4%87%e5%90%88%e8%aa%9e%e5%80%99%e8%a3%9citc106","status":"publish","type":"page","link":"https:\/\/plaza.umin.ac.jp\/~ACP\/home\/a-homepage-section\/acp-japan-chapter-public-relations-committee-2019%e5%b9%b4%e5%ba%a6%e6%b4%bb%e5%8b%95%e6%96%b9%e9%87%9d\/in-the-clinic-season2-%e6%a5%ad%e5%8b%99%e3%83%95%e3%83%ad%e3%83%bc\/%e8%a4%87%e5%90%88%e8%aa%9e%e5%80%99%e8%a3%9citc106","title":{"rendered":"\u8907\u5408\u8a9e\u5019\u88dcITC106"},"content":{"rendered":"\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
\u8907\u5408\u8a9e<\/th>\u30b9\u30b3\u30a2<\/th>\n<\/tr>\n<\/thead>\n
c difficile infection<\/td>1668.7011331905<\/td>\n<\/tr>\n
c difficile<\/td>1053.2740942931<\/td>\n<\/tr>\n
clostridium difficile<\/td>495.9352868501<\/td>\n<\/tr>\n
clostridium difficile infection<\/td>442.26199319078<\/td>\n<\/tr>\n
difficile infection<\/td>373.01004423393<\/td>\n<\/tr>\n
clostridioides difficile infection<\/td>180.98776763299<\/td>\n<\/tr>\n
c diff<\/td>126.57932561791<\/td>\n<\/tr>\n
recurrent clostridium difficile infection<\/td>122.99769398029<\/td>\n<\/tr>\n
disease control<\/td>121.9645608914<\/td>\n<\/tr>\n
severe disease<\/td>115.90734733279<\/td>\n<\/tr>\n
clin infect dis<\/td>106.69979169497<\/td>\n<\/tr>\n
control hosp epidemiol<\/td>95.318600129888<\/td>\n<\/tr>\n
recurrent c difficile infection<\/td>95.060792560648<\/td>\n<\/tr>\n
community-associated clostridium difficile infection<\/td>86.015848239064<\/td>\n<\/tr>\n
community-associated infection<\/td>81.224213202992<\/td>\n<\/tr>\n
prevention of c difficile infection<\/td>67.246081422256<\/td>\n<\/tr>\n
c difficile spores<\/td>53.930665729841<\/td>\n<\/tr>\n
n engl j med<\/td>51.164929659085<\/td>\n<\/tr>\n
c difficile disease<\/td>50.406580679278<\/td>\n<\/tr>\n
antibiotic use<\/td>49.864248143005<\/td>\n<\/tr>\n
treatment of clostridium<\/td>40.72919202836<\/td>\n<\/tr>\n
antibiotic therapy<\/td>36.569668370283<\/td>\n<\/tr>\n
difficile-associated diarrhea<\/td>33.294331602302<\/td>\n<\/tr>\n
transmission of c difficile<\/td>33.226438558303<\/td>\n<\/tr>\n
j hosp infect<\/td>32.776305508147<\/td>\n<\/tr>\n
strain of clostridium difficile<\/td>32.291389455348<\/td>\n<\/tr>\n
transmission of clostridium difficile<\/td>31.922203509308<\/td>\n<\/tr>\n
epidemiology of clostridium difficile infection<\/td>30.31689537615<\/td>\n<\/tr>\n
recurrent clostridium difficile<\/td>29.836255586252<\/td>\n<\/tr>\n
removal of clostridium difficile spores<\/td>29.783613330887<\/td>\n<\/tr>\n
community-associated c difficile infection<\/td>29.546117462411<\/td>\n<\/tr>\n
incidence of c difficile infection<\/td>29.308718495278<\/td>\n<\/tr>\n
oral vancomycin<\/td>29.132540152015<\/td>\n<\/tr>\n
rates of c difficile infection<\/td>28.502508114285<\/td>\n<\/tr>\n
c difficile incidence<\/td>27.987071318917<\/td>\n<\/tr>\n
c difficile testing<\/td>27.667096440907<\/td>\n<\/tr>\n
spores of c difficile<\/td>26.965332864921<\/td>\n<\/tr>\n
hospitalized patients<\/td>26.25816285832<\/td>\n<\/tr>\n
c difficile colitis<\/td>26.158263565308<\/td>\n<\/tr>\n
epidemic of c difficile infection<\/td>26.136915182273<\/td>\n<\/tr>\n
acquisition of clostridium difficile<\/td>25.90686455606<\/td>\n<\/tr>\n
contamination of c difficile<\/td>25.702931742277<\/td>\n<\/tr>\n
clostridium difficile colitis<\/td>25.131475090736<\/td>\n<\/tr>\n
symptomatic c difficile infection<\/td>24.845224258807<\/td>\n<\/tr>\n
risk factors<\/td>24.640562305928<\/td>\n<\/tr>\n
removal of clostridium difficile<\/td>24.213987361732<\/td>\n<\/tr>\n
toxic megacolon<\/td>24<\/td>\n<\/tr>\n
documented c difficile infection<\/td>23.967656899042<\/td>\n<\/tr>\n
difficile diarrhea<\/td>23.960550990666<\/td>\n<\/tr>\n
difficile infection therapy<\/td>23.745230608439<\/td>\n<\/tr>\n
clostridioides difficile<\/td>22.660490046515<\/td>\n<\/tr>\n
c diff infection<\/td>22.244098523821<\/td>\n<\/tr>\n
burden of clostridium difficile infection<\/td>22.109095385155<\/td>\n<\/tr>\n
emergence of clostridium difficile infection<\/td>22.109095385155<\/td>\n<\/tr>\n
clinical practice guidelines<\/td>21.826996516819<\/td>\n<\/tr>\n
carriage of clostridium difficile<\/td>21.572210301634<\/td>\n<\/tr>\n
clostridium difficile carriage<\/td>21.572210301634<\/td>\n<\/tr>\n
infection control<\/td>21.250815646097<\/td>\n<\/tr>\n
toxin eia<\/td>21.013996367098<\/td>\n<\/tr>\n
antibiotic treatment<\/td>20.172748919954<\/td>\n<\/tr>\n
c diff bacteria<\/td>19.872243752912<\/td>\n<\/tr>\n
united states<\/td>19.798989873223<\/td>\n<\/tr>\n
johnson s<\/td>19.679896712654<\/td>\n<\/tr>\n
disease severity<\/td>19.595917942265<\/td>\n<\/tr>\n
national clostridium difficile standards group<\/td>19.244080291168<\/td>\n<\/tr>\n
difficile colitis<\/td>19.055124848007<\/td>\n<\/tr>\n
community-associated disease<\/td>19.027313840044<\/td>\n<\/tr>\n
fulminant infection<\/td>18.160394801798<\/td>\n<\/tr>\n
initial episode of c difficile infection<\/td>18.117875361631<\/td>\n<\/tr>\n
nosocomial acquisition of clostridium difficile infection<\/td>17.925525811314<\/td>\n<\/tr>\n
c difficile toxin b<\/td>17.781811731186<\/td>\n<\/tr>\n
high rates of c difficile infection<\/td>17.718064012515<\/td>\n<\/tr>\n
prevention of clostridium<\/td>17.124515786414<\/td>\n<\/tr>\n
recurrent clostridium difficile colitis<\/td>17.023867839551<\/td>\n<\/tr>\n
nosocomial clostridium difficile diarrhea<\/td>16.78440638966<\/td>\n<\/tr>\n
human infection<\/td>16.409769129251<\/td>\n<\/tr>\n
rate of c difficile infections<\/td>16.143659726751<\/td>\n<\/tr>\n
severity of clostridium difficile colitis<\/td>16.109147138573<\/td>\n<\/tr>\n
complications of clostridioides difficile infection<\/td>16.085138135166<\/td>\n<\/tr>\n
gerding dn<\/td>15.874507866387<\/td>\n<\/tr>\n
intensive care<\/td>15.79288815543<\/td>\n<\/tr>\n
clindamycin-resistant strain of clostridium difficile<\/td>15.540149991467<\/td>\n<\/tr>\n
infection prevention<\/td>15.026595849101<\/td>\n<\/tr>\n
household transmission of clostridium difficile<\/td>14.645304166986<\/td>\n<\/tr>\n
incident c difficile infections<\/td>14.470235185641<\/td>\n<\/tr>\n
mortality of c difficile infections<\/td>14.470235185641<\/td>\n<\/tr>\n
fulminant clostridium difficile colitis<\/td>14.042110668687<\/td>\n<\/tr>\n
successful treatment<\/td>13.817338054791<\/td>\n<\/tr>\n
symptomatic disease<\/td>13.454342644059<\/td>\n<\/tr>\n
recurrent infection<\/td>13.345872924256<\/td>\n<\/tr>\n
difficile nosocomial transmission<\/td>13.300952651184<\/td>\n<\/tr>\n
use of antibiotics<\/td>13.186983011829<\/td>\n<\/tr>\n
fluoroquinolone use<\/td>12.804343491775<\/td>\n<\/tr>\n
difficile forms<\/td>12.74293000222<\/td>\n<\/tr>\n
potential spread of clostridium difficile<\/td>12.522466841623<\/td>\n<\/tr>\n
nonepidemic clostridium difficile strains<\/td>12.522466841623<\/td>\n<\/tr>\n
use of probiotics<\/td>12.383953976879<\/td>\n<\/tr>\n
current status of clostridium difficile infection epidemiology<\/td>12.249917068431<\/td>\n<\/tr>\n
et al<\/td>12.247448713916<\/td>\n<\/tr>\n
j infect dis<\/td>12.238658339601<\/td>\n<\/tr>\n
limit growth of c difficile<\/td>11.833258156059<\/td>\n<\/tr>\n
healthcare infection control practices advisory committee<\/td>11.790476095554<\/td>\n<\/tr>\n
severe infection<\/td>11.78066232612<\/td>\n<\/tr>\n
prospective clostridium<\/td>11.757504990725<\/td>\n<\/tr>\n
infectious diseases society of america<\/td>11.635364684921<\/td>\n<\/tr>\n
clinical cure rate<\/td>11.616764887363<\/td>\n<\/tr>\n
healthcare epidemiology of america<\/td>11.516298621999<\/td>\n<\/tr>\n
incident episode<\/td>11.420262287518<\/td>\n<\/tr>\n
lancet infect dis<\/td>11.323928312453<\/td>\n<\/tr>\n
asymptomatic patients<\/td>11.253498367851<\/td>\n<\/tr>\n
clinical care<\/td>11.132630734855<\/td>\n<\/tr>\n
recurrent disease<\/td>10.942259198939<\/td>\n<\/tr>\n
limbago b. clostridium difficile<\/td>10.915653306933<\/td>\n<\/tr>\n
high risk<\/td>10.767126541911<\/td>\n<\/tr>\n
miller ma<\/td>10.63659179389<\/td>\n<\/tr>\n
increased risk<\/td>10.360080256445<\/td>\n<\/tr>\n
infectious disease<\/td>10.059467437463<\/td>\n<\/tr>\n
kelly c<\/td>9.9292527589406<\/td>\n<\/tr>\n
hand hygiene<\/td>9.8736245044883<\/td>\n<\/tr>\n
severity of disease<\/td>9.7979589711327<\/td>\n<\/tr>\n
clinical trial<\/td>9.7291971163912<\/td>\n<\/tr>\n
asymptomatic colonization<\/td>9.6711293864119<\/td>\n<\/tr>\n
development of clostridium<\/td>9.350399562456<\/td>\n<\/tr>\n
documented c<\/td>9.2402108647231<\/td>\n<\/tr>\n
initial treatment<\/td>9.2115587031938<\/td>\n<\/tr>\n
adult patients<\/td>9.1884429408264<\/td>\n<\/tr>\n
j antimicrob chemother<\/td>8.9924395582992<\/td>\n<\/tr>\n
difficile-associated disease<\/td>8.8534553576026<\/td>\n<\/tr>\n
antibiotic medicines<\/td>8.6195534967901<\/td>\n<\/tr>\n
cochrane database syst rev<\/td>8.4852813742386<\/td>\n<\/tr>\n
infection prevention measures<\/td>8.4221585055181<\/td>\n<\/tr>\n
perry c<\/td>8.3494730511412<\/td>\n<\/tr>\n
zapka c<\/td>8.3494730511412<\/td>\n<\/tr>\n
pindar c<\/td>8.3494730511412<\/td>\n<\/tr>\n
harmanus c<\/td>8.3494730511412<\/td>\n<\/tr>\n
lyons c<\/td>8.3494730511412<\/td>\n<\/tr>\n
patino c<\/td>8.3494730511412<\/td>\n<\/tr>\n
staley c<\/td>8.3494730511412<\/td>\n<\/tr>\n
care?associated infection<\/td>8.2048845646254<\/td>\n<\/tr>\n
care of patients<\/td>8.0617806492789<\/td>\n<\/tr>\n
case-control study<\/td>7.8719586850617<\/td>\n<\/tr>\n
community-acquired clostridium<\/td>7.8627174732592<\/td>\n<\/tr>\n
intravenous metronidazole<\/td>7.6371896850655<\/td>\n<\/tr>\n
likelihood of infection<\/td>7.6355054442122<\/td>\n<\/tr>\n
nasogastric tube<\/td>7.5446005780976<\/td>\n<\/tr>\n
fulminant disease<\/td>7.4448388728168<\/td>\n<\/tr>\n
fecal microbiota transplantation<\/td>7.377854493525<\/td>\n<\/tr>\n
creatinine level<\/td>7.3256830029694<\/td>\n<\/tr>\n
leukocyte count<\/td>7.200411487357<\/td>\n<\/tr>\n
alcohol-based hand products<\/td>7.1450577591353<\/td>\n<\/tr>\n
controlled trials<\/td>6.9282032302755<\/td>\n<\/tr>\n
superimposed infection<\/td>6.899458017964<\/td>\n<\/tr>\n
infection preventionists<\/td>6.899458017964<\/td>\n<\/tr>\n
refractory infection<\/td>6.899458017964<\/td>\n<\/tr>\n
repeated cases of infection<\/td>6.7569628731473<\/td>\n<\/tr>\n
disease development<\/td>6.7271713220297<\/td>\n<\/tr>\n
outbreak settings<\/td>6.700737917669<\/td>\n<\/tr>\n
antibiotic-associated diarrhea<\/td>6.6874030497642<\/td>\n<\/tr>\n
rectal instillation of vancomycin<\/td>6.6489381094792<\/td>\n<\/tr>\n
terminal disinfection<\/td>6.6400915182019<\/td>\n<\/tr>\n
kundrapu s<\/td>6.6195018392937<\/td>\n<\/tr>\n
judicious antibiotic use<\/td>6.456637412915<\/td>\n<\/tr>\n
recent antibiotic use<\/td>6.456637412915<\/td>\n<\/tr>\n
duration of use<\/td>6.4021717458874<\/td>\n<\/tr>\n
sporicidal agent<\/td>6.3442275806434<\/td>\n<\/tr>\n
wilcox mh<\/td>6.3442275806434<\/td>\n<\/tr>\n
increased incidence<\/td>6.160140576482<\/td>\n<\/tr>\n
ann intern med<\/td>6.1336249480655<\/td>\n<\/tr>\n
updated idsa\/shea guidelines<\/td>6.1249938046775<\/td>\n<\/tr>\n
difficile-associated disease surveillance<\/td>6.0523429976916<\/td>\n<\/tr>\n
loo vg<\/td>6<\/td>\n<\/tr>\n
multistep algorithm<\/td>6<\/td>\n<\/tr>\n
pulsed-dose regimen<\/td>6<\/td>\n<\/tr>\n
mcfarland lv<\/td>6<\/td>\n<\/tr>\n
appropriate use<\/td>5.957892135529<\/td>\n<\/tr>\n
routine infection prevention practices<\/td>5.930215283947<\/td>\n<\/tr>\n
mild diarrhea<\/td>5.8856619127654<\/td>\n<\/tr>\n
appropriate management of infection<\/td>5.867080788972<\/td>\n<\/tr>\n
elevated creatinine levels<\/td>5.8083824436817<\/td>\n<\/tr>\n
am j med<\/td>5.7409603581847<\/td>\n<\/tr>\n
controlled study of vinyl glove use<\/td>5.7382461721454<\/td>\n<\/tr>\n
use of gloves<\/td>5.6924250976222<\/td>\n<\/tr>\n
nonsevere disease<\/td>5.6568542494924<\/td>\n<\/tr>\n
proximal disease<\/td>5.6568542494924<\/td>\n<\/tr>\n
clinical resolution of diarrhea<\/td>5.5742555610179<\/td>\n<\/tr>\n
lactate level<\/td>5.5663153674275<\/td>\n<\/tr>\n
brazier j<\/td>5.5044086707916<\/td>\n<\/tr>\n
j clin microbiol<\/td>5.4953326820861<\/td>\n<\/tr>\n
outpatient treatment<\/td>5.4772255750517<\/td>\n<\/tr>\n
treatment of incident<\/td>5.4772255750517<\/td>\n<\/tr>\n
clinical guidelines<\/td>5.446539630663<\/td>\n<\/tr>\n
outbreak setting<\/td>5.4216120216591<\/td>\n<\/tr>\n
additional infection prevention measures<\/td>5.3913348647212<\/td>\n<\/tr>\n
prospective study<\/td>5.318295896945<\/td>\n<\/tr>\n
emergency department<\/td>5.26429605181<\/td>\n<\/tr>\n
infectious disease specialist<\/td>5.2306419440473<\/td>\n<\/tr>\n
infectious disease specialists<\/td>5.2306419440473<\/td>\n<\/tr>\n
toxin testing<\/td>5.1943695600587<\/td>\n<\/tr>\n
instillation of stool<\/td>5.1800401282227<\/td>\n<\/tr>\n
toxigenic culture<\/td>5.1800401282227<\/td>\n<\/tr>\n
underlying disease severity<\/td>5.1395931737013<\/td>\n<\/tr>\n
pattern of disease severity<\/td>5.1395931737013<\/td>\n<\/tr>\n
alcohol-based hand<\/td>5.1307790014945<\/td>\n<\/tr>\n
advanced hiv infection<\/td>5.1253671622755<\/td>\n<\/tr>\n
use of vinyl gloves<\/td>5.0607888021286<\/td>\n<\/tr>\n
gastrointestinal tract<\/td>5.0297337187317<\/td>\n<\/tr>\n
clinical evidence<\/td>5.0297337187317<\/td>\n<\/tr>\n
health care providers<\/td>5.0264737531022<\/td>\n<\/tr>\n
such use<\/td>5.0099701392346<\/td>\n<\/tr>\n
environmental transmission<\/td>5.0099701392346<\/td>\n<\/tr>\n
leischner j<\/td>4.9737947036147<\/td>\n<\/tr>\n
corver j<\/td>4.9737947036147<\/td>\n<\/tr>\n
pepin j<\/td>4.9737947036147<\/td>\n<\/tr>\n
sauk j<\/td>4.9737947036147<\/td>\n<\/tr>\n
hammond j<\/td>4.9737947036147<\/td>\n<\/tr>\n
p?pin j<\/td>4.9737947036147<\/td>\n<\/tr>\n
patient information<\/td>4.8989794855664<\/td>\n<\/tr>\n
hospital outbreak<\/td>4.8205705136679<\/td>\n<\/tr>\n
nelson r. antibiotic treatment<\/td>4.7949934056896<\/td>\n<\/tr>\n
gerber r<\/td>4.7935634538569<\/td>\n<\/tr>\n
clonal multi-institutional outbreak of clostridium<\/td>4.7857818399046<\/td>\n<\/tr>\n
outpatient health care environment<\/td>4.7093283475797<\/td>\n<\/tr>\n
cure rate<\/td>4.6806946386414<\/td>\n<\/tr>\n
risk factor<\/td>4.6806946386414<\/td>\n<\/tr>\n
observational study<\/td>4.6806946386414<\/td>\n<\/tr>\n
30-day mortality<\/td>4.6806946386414<\/td>\n<\/tr>\n
weiss k<\/td>4.6806946386414<\/td>\n<\/tr>\n
protocol analysis<\/td>4.6806946386414<\/td>\n<\/tr>\n
toxin tests<\/td>4.651161968023<\/td>\n<\/tr>\n
instillation of vancomycin<\/td>4.6057793515969<\/td>\n<\/tr>\n
147.2 cases<\/td>4.5825756949558<\/td>\n<\/tr>\n
ischemic bowel disease<\/td>4.5788569702133<\/td>\n<\/tr>\n
inflammatory bowel disease<\/td>4.5788569702133<\/td>\n<\/tr>\n
stool tests<\/td>4.5590141139096<\/td>\n<\/tr>\n
asymptomatic carriers<\/td>4.5590141139096<\/td>\n<\/tr>\n
kasper d<\/td>4.5590141139096<\/td>\n<\/tr>\n
patient rooms<\/td>4.5590141139096<\/td>\n<\/tr>\n
modified intention-to-treat analysis<\/td>4.5298688016454<\/td>\n<\/tr>\n
clindamycin use<\/td>4.5270190558379<\/td>\n<\/tr>\n
unnecessary use<\/td>4.5270190558379<\/td>\n<\/tr>\n
short-term use<\/td>4.5270190558379<\/td>\n<\/tr>\n
other diseases<\/td>4.5270190558379<\/td>\n<\/tr>\n
laxative use<\/td>4.5270190558379<\/td>\n<\/tr>\n
nosocomial transmission<\/td>4.5270190558379<\/td>\n<\/tr>\n
community-associated diarrhea<\/td>4.4721359549996<\/td>\n<\/tr>\n
controlled pilot study<\/td>4.4418123097047<\/td>\n<\/tr>\n
terminal cleaning<\/td>4.4267276788013<\/td>\n<\/tr>\n
care of someone<\/td>4.4267276788013<\/td>\n<\/tr>\n
receipt of care<\/td>4.4267276788013<\/td>\n<\/tr>\n
stewardship protocols<\/td>4.4267276788013<\/td>\n<\/tr>\n
immunocompromised persons<\/td>4.4267276788013<\/td>\n<\/tr>\n
family members<\/td>4.4267276788013<\/td>\n<\/tr>\n
resolution of diarrhea<\/td>4.400558683967<\/td>\n<\/tr>\n
open forum infect dis<\/td>4.364985804658<\/td>\n<\/tr>\n
nursing home care<\/td>4.3644945438869<\/td>\n<\/tr>\n
treatment options<\/td>4.3558771746929<\/td>\n<\/tr>\n
severe cases<\/td>4.3467739333546<\/td>\n<\/tr>\n
antibiotic disruption<\/td>4.3097767483951<\/td>\n<\/tr>\n
medical therapy<\/td>4.2813902858562<\/td>\n<\/tr>\n
community-associated cases<\/td>4.2813902858562<\/td>\n<\/tr>\n
transmission of infectious agents<\/td>4.2484406376281<\/td>\n<\/tr>\n
significant reduction<\/td>4.2294850537623<\/td>\n<\/tr>\n
first study<\/td>4.2294850537623<\/td>\n<\/tr>\n
judicious use of antibiotics<\/td>4.2227675591121<\/td>\n<\/tr>\n
prevention measures<\/td>4.2128659306105<\/td>\n<\/tr>\n
cases of contact<\/td>4.2128659306105<\/td>\n<\/tr>\n
other complications<\/td>4.2128659306105<\/td>\n<\/tr>\n
infectious complications<\/td>4.1617914502878<\/td>\n<\/tr>\n
clinical success of metronidazole<\/td>4.1406808334653<\/td>\n<\/tr>\n
donor stool<\/td>4.1195342878142<\/td>\n<\/tr>\n
placebo-controlled trials<\/td>4.1195342878142<\/td>\n<\/tr>\n
dis clin north am<\/td>4.1175193504392<\/td>\n<\/tr>\n
opt-80-004 clinical study group<\/td>4.080093847101<\/td>\n<\/tr>\n
opt-80-003 clinical study group<\/td>4.080093847101<\/td>\n<\/tr>\n
long-term care facility<\/td>4.079297805311<\/td>\n<\/tr>\n
hypervirulent strain<\/td>4.0536004644211<\/td>\n<\/tr>\n
treatment strategies<\/td>4.0536004644211<\/td>\n<\/tr>\n
epidemic strain<\/td>4.0536004644211<\/td>\n<\/tr>\n
noninfectious causes<\/td>4<\/td>\n<\/tr>\n
department of health<\/td>3.9842826037303<\/td>\n<\/tr>\n
transmission of epidemic<\/td>3.9842826037303<\/td>\n<\/tr>\n
person-to-person transmission<\/td>3.9842826037303<\/td>\n<\/tr>\n
other strains<\/td>3.9842826037303<\/td>\n<\/tr>\n
other factors<\/td>3.9842826037303<\/td>\n<\/tr>\n
direct inspection<\/td>3.9359793425309<\/td>\n<\/tr>\n
olson mm<\/td>3.9359793425309<\/td>\n<\/tr>\n
retrospective study<\/td>3.9359793425309<\/td>\n<\/tr>\n
risk increases<\/td>3.9359793425309<\/td>\n<\/tr>\n
antibiotic policy<\/td>3.8943229049609<\/td>\n<\/tr>\n
colonized health care personnel<\/td>3.8511259398089<\/td>\n<\/tr>\n
extended use of metronidazole<\/td>3.7849303181582<\/td>\n<\/tr>\n
known risk factors<\/td>3.7719455481171<\/td>\n<\/tr>\n
established risk factors<\/td>3.7719455481171<\/td>\n<\/tr>\n
hand sanitizer<\/td>3.7511661226171<\/td>\n<\/tr>\n
antibiotic prescription protocol<\/td>3.745284791174<\/td>\n<\/tr>\n
repeated stool testing<\/td>3.7288210710016<\/td>\n<\/tr>\n
advanced age<\/td>3.7224194364084<\/td>\n<\/tr>\n
farm animals<\/td>3.7224194364084<\/td>\n<\/tr>\n
bakken js<\/td>3.7224194364084<\/td>\n<\/tr>\n
lessa fc<\/td>3.7224194364084<\/td>\n<\/tr>\n
flexible sigmoidoscopy<\/td>3.7224194364084<\/td>\n<\/tr>\n
donskey cj<\/td>3.7224194364084<\/td>\n<\/tr>\n
libman md<\/td>3.7224194364084<\/td>\n<\/tr>\n
supplemental intervention<\/td>3.7224194364084<\/td>\n<\/tr>\n
bamberg wm<\/td>3.7224194364084<\/td>\n<\/tr>\n
clabots cr<\/td>3.7224194364084<\/td>\n<\/tr>\n
other bacteria<\/td>3.7077927510673<\/td>\n<\/tr>\n
other tests<\/td>3.7077927510673<\/td>\n<\/tr>\n
other antibiotics<\/td>3.7077927510673<\/td>\n<\/tr>\n
other studies<\/td>3.7077927510673<\/td>\n<\/tr>\n
recent outpatient health care visit<\/td>3.7022878087468<\/td>\n<\/tr>\n
empirical treatment<\/td>3.6628415014847<\/td>\n<\/tr>\n
cdi treatment<\/td>3.6628415014847<\/td>\n<\/tr>\n
aggressive treatment<\/td>3.6628415014847<\/td>\n<\/tr>\n
first recurrent episode<\/td>3.6467519140054<\/td>\n<\/tr>\n
long-term care residents<\/td>3.6342411856643<\/td>\n<\/tr>\n
other laboratory tests<\/td>3.6247148052866<\/td>\n<\/tr>\n
care?associated transmission<\/td>3.6002057436785<\/td>\n<\/tr>\n
potential drug treatment<\/td>3.5953592505049<\/td>\n<\/tr>\n
faecal enema treatment<\/td>3.5953592505049<\/td>\n<\/tr>\n
idsa\/shea guidelines<\/td>3.5840246342157<\/td>\n<\/tr>\n
successful use of feedback<\/td>3.578518080138<\/td>\n<\/tr>\n
same episode of diarrhea<\/td>3.578518080138<\/td>\n<\/tr>\n
one study<\/td>3.5565588200778<\/td>\n<\/tr>\n
second study<\/td>3.5565588200778<\/td>\n<\/tr>\n
clinical features<\/td>3.5565588200778<\/td>\n<\/tr>\n
toxin detection<\/td>3.5341188430494<\/td>\n<\/tr>\n
toxin eias<\/td>3.5341188430494<\/td>\n<\/tr>\n
interrupted time-series study<\/td>3.5254687665352<\/td>\n<\/tr>\n
antibiotic stewardship programs<\/td>3.5005501496846<\/td>\n<\/tr>\n
practice improvement<\/td>3.4996355115806<\/td>\n<\/tr>\n
h2-receptor blockers<\/td>3.4641016151377<\/td>\n<\/tr>\n
cornely oa<\/td>3.4641016151377<\/td>\n<\/tr>\n
proton-pump inhibitors<\/td>3.4641016151377<\/td>\n<\/tr>\n
10-day course<\/td>3.4641016151377<\/td>\n<\/tr>\n
acute care hospitals<\/td>3.4641016151377<\/td>\n<\/tr>\n
systematic review<\/td>3.4641016151377<\/td>\n<\/tr>\n
body fluids<\/td>3.4641016151377<\/td>\n<\/tr>\n
colonization rates<\/td>3.4641016151377<\/td>\n<\/tr>\n
stool transplant<\/td>3.4641016151377<\/td>\n<\/tr>\n
septic shock<\/td>3.4641016151377<\/td>\n<\/tr>\n
stamm we<\/td>3.4641016151377<\/td>\n<\/tr>\n
louie tj<\/td>3.4641016151377<\/td>\n<\/tr>\n
multidrug-resistant organism<\/td>3.4641016151377<\/td>\n<\/tr>\n
mcdonald lc<\/td>3.4641016151377<\/td>\n<\/tr>\n
results of stool studies<\/td>3.4641016151377<\/td>\n<\/tr>\n
fawley wn<\/td>3.4641016151377<\/td>\n<\/tr>\n
fresh stool<\/td>3.4641016151377<\/td>\n<\/tr>\n
suissa s. use<\/td>3.4478752740675<\/td>\n<\/tr>\n
prospective controlled trial<\/td>3.4478752740675<\/td>\n<\/tr>\n
main antibiotic agents<\/td>3.4235051013067<\/td>\n<\/tr>\n
10-year prospective study<\/td>3.4199518933534<\/td>\n<\/tr>\n
diagnostic tests<\/td>3.4086580994025<\/td>\n<\/tr>\n
clindamycin-resistant strain<\/td>3.4086580994025<\/td>\n<\/tr>\n
virulent strain<\/td>3.4086580994025<\/td>\n<\/tr>\n
strain present<\/td>3.4086580994025<\/td>\n<\/tr>\n
fecal microbiota transplant<\/td>3.3878587775517<\/td>\n<\/tr>\n
clinical success of tolevamer<\/td>3.3604214537127<\/td>\n<\/tr>\n
intestinal microbiota<\/td>3.3503689588345<\/td>\n<\/tr>\n
alcohol-based hand gel<\/td>3.3390829273101<\/td>\n<\/tr>\n
alcohol-based hand sanitizers<\/td>3.3390829273101<\/td>\n<\/tr>\n
difficile-associated colitis<\/td>3.3097509196469<\/td>\n<\/tr>\n
shah s<\/td>3.3097509196469<\/td>\n<\/tr>\n
long-term care facility residents<\/td>3.292905106941<\/td>\n<\/tr>\n
faecal microbiota transplantation<\/td>3.2864605554537<\/td>\n<\/tr>\n
scand j gastroenterol<\/td>3.2706211157025<\/td>\n<\/tr>\n
thorough hand hygiene<\/td>3.2543885763655<\/td>\n<\/tr>\n
strict hand hygiene<\/td>3.2543885763655<\/td>\n<\/tr>\n
effectiveness of hand hygiene<\/td>3.2543885763655<\/td>\n<\/tr>\n
healthcare settings<\/td>3.2531531233956<\/td>\n<\/tr>\n
medical equipment<\/td>3.2531531233956<\/td>\n<\/tr>\n
high leukocyte count<\/td>3.2488866055632<\/td>\n<\/tr>\n
retrospective observational cohort study of patients<\/td>3.2380572012303<\/td>\n<\/tr>\n
fecal contamination<\/td>3.2237097954706<\/td>\n<\/tr>\n
outpatient healthcare settings<\/td>3.2225747786052<\/td>\n<\/tr>\n
gaese c. risk factors<\/td>3.2187078550942<\/td>\n<\/tr>\n
effects of control interventions<\/td>3.2031009475288<\/td>\n<\/tr>\n
many cases<\/td>3.2010858729437<\/td>\n<\/tr>\n
ajr am j roentgenol<\/td>3.2007591148109<\/td>\n<\/tr>\n
toxin production<\/td>3.1934368675747<\/td>\n<\/tr>\n
binary toxin<\/td>3.1934368675747<\/td>\n<\/tr>\n
severe illness<\/td>3.1779718278113<\/td>\n<\/tr>\n
increased leukocyte count<\/td>3.1664800441388<\/td>\n<\/tr>\n
recognized risk factor<\/td>3.14083560495<\/td>\n<\/tr>\n
major risk factor<\/td>3.14083560495<\/td>\n<\/tr>\n
clinical illness ranges<\/td>3.14083560495<\/td>\n<\/tr>\n
overall cure rate<\/td>3.14083560495<\/td>\n<\/tr>\n
stool frequency<\/td>3.1301691601466<\/td>\n<\/tr>\n
duration of therapy<\/td>3.1301691601466<\/td>\n<\/tr>\n
stool consistency<\/td>3.1301691601466<\/td>\n<\/tr>\n
stool softeners<\/td>3.1301691601466<\/td>\n<\/tr>\n
previous hospital<\/td>3.080070288241<\/td>\n<\/tr>\n
different strain<\/td>3.080070288241<\/td>\n<\/tr>\n
concomitant vancomycin<\/td>3.080070288241<\/td>\n<\/tr>\n
immunocompromised patients<\/td>3.0628143136088<\/td>\n<\/tr>\n
fresh fecal microbiota transplantation<\/td>3.0536216384903<\/td>\n<\/tr>\n
new hypervirulent strain<\/td>3.0531455120681<\/td>\n<\/tr>\n
health history<\/td>3.0274001040351<\/td>\n<\/tr>\n
other information<\/td>3.0274001040351<\/td>\n<\/tr>\n
identified health<\/td>3.0274001040351<\/td>\n<\/tr>\n
several factors<\/td>3.0274001040351<\/td>\n<\/tr>\n
health professionals<\/td>3.0274001040351<\/td>\n<\/tr>\n
critical care units<\/td>3.0261714988458<\/td>\n<\/tr>\n
incidence rate ratio<\/td>2.9937951655239<\/td>\n<\/tr>\n
nnesen s<\/td>2.9906975624424<\/td>\n<\/tr>\n
puumala s<\/td>2.9906975624424<\/td>\n<\/tr>\n
weese s<\/td>2.9906975624424<\/td>\n<\/tr>\n
leekha s<\/td>2.9906975624424<\/td>\n<\/tr>\n
infectious causes<\/td>2.9906975624424<\/td>\n<\/tr>\n
fenn s<\/td>2.9906975624424<\/td>\n<\/tr>\n
fowler s<\/td>2.9906975624424<\/td>\n<\/tr>\n
michaud s<\/td>2.9906975624424<\/td>\n<\/tr>\n
fuentes s<\/td>2.9906975624424<\/td>\n<\/tr>\n
dial s<\/td>2.9906975624424<\/td>\n<\/tr>\n
chasan-taber s<\/td>2.9906975624424<\/td>\n<\/tr>\n
sougioultzis s<\/td>2.9906975624424<\/td>\n<\/tr>\n
normal leukocyte count<\/td>2.9595672453546<\/td>\n<\/tr>\n
type of diarrhea<\/td>2.9428309563827<\/td>\n<\/tr>\n
direct contact<\/td>2.9428309563827<\/td>\n<\/tr>\n
persistent diarrhea<\/td>2.9428309563827<\/td>\n<\/tr>\n
recommended practices<\/td>2.9428309563827<\/td>\n<\/tr>\n
standard course<\/td>2.9129506302439<\/td>\n<\/tr>\n
appropriate therapy<\/td>2.9129506302439<\/td>\n<\/tr>\n
colectomy rates<\/td>2.9129506302439<\/td>\n<\/tr>\n
normal creatinine levels<\/td>2.9041912218409<\/td>\n<\/tr>\n
high mortality<\/td>2.8925076085191<\/td>\n<\/tr>\n
oral metronidazole<\/td>2.8925076085191<\/td>\n<\/tr>\n
standard 10-day course<\/td>2.8844991406148<\/td>\n<\/tr>\n
other ggood h bacteria<\/td>2.8647328669885<\/td>\n<\/tr>\n
gj strain h<\/td>2.8536385282275<\/td>\n<\/tr>\n
colonized patients<\/td>2.8502698827718<\/td>\n<\/tr>\n
infected patients<\/td>2.8502698827718<\/td>\n<\/tr>\n
shetty n<\/td>2.8284271247462<\/td>\n<\/tr>\n
stoesser n<\/td>2.8284271247462<\/td>\n<\/tr>\n
dendukuri n<\/td>2.8284271247462<\/td>\n<\/tr>\n
laboratory testing method<\/td>2.8210130123402<\/td>\n<\/tr>\n
such cases<\/td>2.8173132472613<\/td>\n<\/tr>\n
several tests<\/td>2.8173132472613<\/td>\n<\/tr>\n
several studies<\/td>2.8173132472613<\/td>\n<\/tr>\n
efficacy of vinyl gloves<\/td>2.7981664143395<\/td>\n<\/tr>\n
duration of contact precautions<\/td>2.7981664143395<\/td>\n<\/tr>\n
s boulardii fungemia<\/td>2.7981664143395<\/td>\n<\/tr>\n
hospital administrators<\/td>2.7831576837137<\/td>\n<\/tr>\n
hospital epidemiologists<\/td>2.7831576837137<\/td>\n<\/tr>\n
comparison of vancomycin<\/td>2.7831576837137<\/td>\n<\/tr>\n
fulminant colitis<\/td>2.7831576837137<\/td>\n<\/tr>\n
contact precautions<\/td>2.7831576837137<\/td>\n<\/tr>\n
administered vancomycin<\/td>2.7831576837137<\/td>\n<\/tr>\n
poirier a<\/td>2.7831576837137<\/td>\n<\/tr>\n
direct person-to-person contact<\/td>2.7682294565183<\/td>\n<\/tr>\n
disposable medical equipment<\/td>2.766175108537<\/td>\n<\/tr>\n
10-day course of fidaxomicin<\/td>2.7494592739972<\/td>\n<\/tr>\n
several diagnostic options<\/td>2.736580418555<\/td>\n<\/tr>\n
recurrent symptoms<\/td>2.7355647997348<\/td>\n<\/tr>\n
repeated testing<\/td>2.7355647997348<\/td>\n<\/tr>\n
medical therapies<\/td>2.7355647997348<\/td>\n<\/tr>\n
many commercial toxin eias<\/td>2.7338162726212<\/td>\n<\/tr>\n
jama intern med<\/td>2.7322193018926<\/td>\n<\/tr>\n
updated guidelines<\/td>2.7232698153315<\/td>\n<\/tr>\n
similar severity<\/td>2.7108060108295<\/td>\n<\/tr>\n
imaging tests<\/td>2.7108060108295<\/td>\n<\/tr>\n
hospitalized persons<\/td>2.7108060108295<\/td>\n<\/tr>\n
imaging studies<\/td>2.7108060108295<\/td>\n<\/tr>\n
other opportunistic pathogens<\/td>2.6889452937027<\/td>\n<\/tr>\n
other opportunistic organisms<\/td>2.6889452937027<\/td>\n<\/tr>\n
severe dehydration<\/td>2.6723451177838<\/td>\n<\/tr>\n
tissue culture laboratory<\/td>2.66716827534<\/td>\n<\/tr>\n
prevention web site<\/td>2.66716827534<\/td>\n<\/tr>\n
cessation of diarrhea<\/td>2.6591479484725<\/td>\n<\/tr>\n
epidemics of diarrhea<\/td>2.6591479484725<\/td>\n<\/tr>\n
antibiotic-related diarrhea<\/td>2.6591479484725<\/td>\n<\/tr>\n
drug-associated diarrhea<\/td>2.6591479484725<\/td>\n<\/tr>\n
lactate levels<\/td>2.6591479484725<\/td>\n<\/tr>\n
randomised controlled trial<\/td>2.6366746651365<\/td>\n<\/tr>\n
other physical manipulations<\/td>2.6366746651365<\/td>\n<\/tr>\n
potential source of community acquisition<\/td>2.632148025905<\/td>\n<\/tr>\n
multiple factors<\/td>2.632148025905<\/td>\n<\/tr>\n
controlled interrupted time series<\/td>2.632148025905<\/td>\n<\/tr>\n
glove removal<\/td>2.632148025905<\/td>\n<\/tr>\n
care?associated colonization<\/td>2.632148025905<\/td>\n<\/tr>\n
north america<\/td>2.632148025905<\/td>\n<\/tr>\n
rate of relapse<\/td>2.632148025905<\/td>\n<\/tr>\n
potential source<\/td>2.632148025905<\/td>\n<\/tr>\n
physical examination<\/td>2.632148025905<\/td>\n<\/tr>\n
unstable clinical condition<\/td>2.6153209720237<\/td>\n<\/tr>\n
reported incidence<\/td>2.5900200641113<\/td>\n<\/tr>\n
environmental surfaces<\/td>2.5900200641113<\/td>\n<\/tr>\n
resolution of fever<\/td>2.5900200641113<\/td>\n<\/tr>\n
noninfectious complications of fmt<\/td>2.5873402367724<\/td>\n<\/tr>\n
hospitalised patients<\/td>2.5755095769014<\/td>\n<\/tr>\n
survival of patients<\/td>2.5755095769014<\/td>\n<\/tr>\n
select patients<\/td>2.5755095769014<\/td>\n<\/tr>\n
other tools<\/td>2.5457298950218<\/td>\n<\/tr>\n
other conditions<\/td>2.5457298950218<\/td>\n<\/tr>\n
other circumstances<\/td>2.5457298950218<\/td>\n<\/tr>\n
other mechanisms<\/td>2.5457298950218<\/td>\n<\/tr>\n
other methods<\/td>2.5457298950218<\/td>\n<\/tr>\n
other species<\/td>2.5457298950218<\/td>\n<\/tr>\n
individual cases<\/td>2.5457298950218<\/td>\n<\/tr>\n
flexible tube<\/td>2.5148668593659<\/td>\n<\/tr>\n
nematallah a<\/td>2.5148668593659<\/td>\n<\/tr>\n
pillai a<\/td>2.5148668593659<\/td>\n<\/tr>\n
berstad a<\/td>2.5148668593659<\/td>\n<\/tr>\n
birtles a<\/td>2.5148668593659<\/td>\n<\/tr>\n
gustafsson a<\/td>2.5148668593659<\/td>\n<\/tr>\n
goorhuis a<\/td>2.5148668593659<\/td>\n<\/tr>\n
khoruts a<\/td>2.5148668593659<\/td>\n<\/tr>\n
mutreja a<\/td>2.5148668593659<\/td>\n<\/tr>\n
fang a<\/td>2.5148668593659<\/td>\n<\/tr>\n
anand a<\/td>2.5148668593659<\/td>\n<\/tr>\n
thibault a<\/td>2.5148668593659<\/td>\n<\/tr>\n
recommended duration<\/td>2.5148668593659<\/td>\n<\/tr>\n
phimister a<\/td>2.5148668593659<\/td>\n<\/tr>\n
lewis a<\/td>2.5148668593659<\/td>\n<\/tr>\n
lentnek a<\/td>2.5148668593659<\/td>\n<\/tr>\n
pelletier a<\/td>2.5148668593659<\/td>\n<\/tr>\n
thompson a<\/td>2.5148668593659<\/td>\n<\/tr>\n
webber a<\/td>2.5148668593659<\/td>\n<\/tr>\n
vrieze a<\/td>2.5148668593659<\/td>\n<\/tr>\n
open med<\/td>2.4989993994394<\/td>\n<\/tr>\n
elevated lactate level<\/td>2.4928828716784<\/td>\n<\/tr>\n
large teaching hospital<\/td>2.4928828716784<\/td>\n<\/tr>\n
measurement of serum creatinine<\/td>2.4928828716784<\/td>\n<\/tr>\n
uniforms of hospital workers<\/td>2.4928828716784<\/td>\n<\/tr>\n
appropriate daily environmental cleaning<\/td>2.481963048976<\/td>\n<\/tr>\n
nursing home exposure<\/td>2.4494897427832<\/td>\n<\/tr>\n
virulent strains<\/td>2.4494897427832<\/td>\n<\/tr>\n
likelihood of acquisition<\/td>2.4494897427832<\/td>\n<\/tr>\n
laboratory values<\/td>2.4494897427832<\/td>\n<\/tr>\n
polymer alternative<\/td>2.4494897427832<\/td>\n<\/tr>\n
alternative diagnosis<\/td>2.4494897427832<\/td>\n<\/tr>\n
standard course of fidaxomicin<\/td>2.4494897427832<\/td>\n<\/tr>\n
certain factors<\/td>2.4494897427832<\/td>\n<\/tr>\n
antibiotic-associated pseudomembranous colitis<\/td>2.418271175122<\/td>\n<\/tr>\n
oughton m<\/td>2.3967817269284<\/td>\n<\/tr>\n
nelson r. probiotics<\/td>2.3955779153092<\/td>\n<\/tr>\n
common source<\/td>2.3784142300054<\/td>\n<\/tr>\n
physical findings<\/td>2.3784142300054<\/td>\n<\/tr>\n
similar hospital wards<\/td>2.376176797565<\/td>\n<\/tr>\n
modernising medical microbiology informatics group<\/td>2.3607278634909<\/td>\n<\/tr>\n
gastric acid-suppressive agents<\/td>2.3490100793233<\/td>\n<\/tr>\n
ma ss<\/td>2.3403473193207<\/td>\n<\/tr>\n
idsa\/shea guideline<\/td>2.3403473193207<\/td>\n<\/tr>\n
resolution of leukocytosis<\/td>2.3403473193207<\/td>\n<\/tr>\n
diagnostic value<\/td>2.3403473193207<\/td>\n<\/tr>\n
symptom resolution<\/td>2.3403473193207<\/td>\n<\/tr>\n
abdominal imaging<\/td>2.3403473193207<\/td>\n<\/tr>\n
presence of complications<\/td>2.3403473193207<\/td>\n<\/tr>\n
nucleic acid amplification tests<\/td>2.3284355309218<\/td>\n<\/tr>\n
further testing<\/td>2.3003266337912<\/td>\n<\/tr>\n
multiple types of antibiotics<\/td>2.2894284851067<\/td>\n<\/tr>\n
limited studies<\/td>2.2795070569548<\/td>\n<\/tr>\n
certain antibiotics<\/td>2.2795070569548<\/td>\n<\/tr>\n
randomized studies<\/td>2.2795070569548<\/td>\n<\/tr>\n
type of bacteria<\/td>2.2795070569548<\/td>\n<\/tr>\n
o fmalley cm jr<\/td>2.2759701509955<\/td>\n<\/tr>\n
minneapolis va medical center<\/td>2.2564263316234<\/td>\n<\/tr>\n
initial improvement<\/td>2.2360679774998<\/td>\n<\/tr>\n
antegrade vancomycin lavage<\/td>2.2209061548523<\/td>\n<\/tr>\n
abdominal examination findings<\/td>2.2209061548523<\/td>\n<\/tr>\n
case series<\/td>2.2133638394006<\/td>\n<\/tr>\n
fusidic acid<\/td>2.2133638394006<\/td>\n<\/tr>\n
poirier l<\/td>2.2133638394006<\/td>\n<\/tr>\n
enteric pathogen<\/td>2.2133638394006<\/td>\n<\/tr>\n
hardy spores<\/td>2.2133638394006<\/td>\n<\/tr>\n
same effect<\/td>2.2133638394006<\/td>\n<\/tr>\n
nontoxigenic strains<\/td>2.2133638394006<\/td>\n<\/tr>\n
delivery of therapy<\/td>2.2133638394006<\/td>\n<\/tr>\n
evidence of perforation<\/td>2.2133638394006<\/td>\n<\/tr>\n
resistant strains<\/td>2.2133638394006<\/td>\n<\/tr>\n
jones e. bacterial contamination of uniforms<\/td>2.1946410573398<\/td>\n<\/tr>\n
woodhouse k. gastric acid suppression<\/td>2.1946410573398<\/td>\n<\/tr>\n
norin e. faecal<\/td>2.1822472719434<\/td>\n<\/tr>\n
american college of physicians<\/td>2.1822472719434<\/td>\n<\/tr>\n
nathan r<\/td>2.165736770668<\/td>\n<\/tr>\n
marshall r<\/td>2.165736770668<\/td>\n<\/tr>\n
ricciardi r<\/td>2.165736770668<\/td>\n<\/tr>\n
lalancette m<\/td>2.165736770668<\/td>\n<\/tr>\n
periodic guidelines<\/td>2.165736770668<\/td>\n<\/tr>\n
jackson m<\/td>2.165736770668<\/td>\n<\/tr>\n
abd m<\/td>2.165736770668<\/td>\n<\/tr>\n
warny m<\/td>2.165736770668<\/td>\n<\/tr>\n
craig r<\/td>2.165736770668<\/td>\n<\/tr>\n
nieuwdorp m<\/td>2.165736770668<\/td>\n<\/tr>\n
smieja m<\/td>2.165736770668<\/td>\n<\/tr>\n
esposito r<\/td>2.165736770668<\/td>\n<\/tr>\n
alani m<\/td>2.165736770668<\/td>\n<\/tr>\n
bendall r<\/td>2.165736770668<\/td>\n<\/tr>\n
shemko m<\/td>2.165736770668<\/td>\n<\/tr>\n
mccormack r<\/td>2.165736770668<\/td>\n<\/tr>\n
pattani r<\/td>2.165736770668<\/td>\n<\/tr>\n
barnden m<\/td>2.165736770668<\/td>\n<\/tr>\n
killgore g<\/td>2.1406951429281<\/td>\n<\/tr>\n
effects of probiotics<\/td>2.1406951429281<\/td>\n<\/tr>\n
randomized trial<\/td>2.1406951429281<\/td>\n<\/tr>\n
antineoplastic agents<\/td>2.1406951429281<\/td>\n<\/tr>\n
deshpande a. colonization<\/td>2.1398263878673<\/td>\n<\/tr>\n
common enteric pathogen<\/td>2.1398263878673<\/td>\n<\/tr>\n
strains of escherichia coli<\/td>2.1398263878673<\/td>\n<\/tr>\n
urinary tract infections<\/td>2.1398263878673<\/td>\n<\/tr>\n
impact of emergency colectomy<\/td>2.1398263878673<\/td>\n<\/tr>\n
reported efficacy of fmt<\/td>2.1169328630255<\/td>\n<\/tr>\n
various diagnostic assays<\/td>2.1169328630255<\/td>\n<\/tr>\n
solomon k<\/td>2.1147425268811<\/td>\n<\/tr>\n
thorlund k<\/td>2.1147425268811<\/td>\n<\/tr>\n
antibiotic-associated diarrhoea<\/td>2.1147425268811<\/td>\n<\/tr>\n
keel k<\/td>2.1147425268811<\/td>\n<\/tr>\n
savik k<\/td>2.1147425268811<\/td>\n<\/tr>\n
total mortality<\/td>2.1147425268811<\/td>\n<\/tr>\n
tube feeding<\/td>2.1147425268811<\/td>\n<\/tr>\n
oral medication<\/td>2.1147425268811<\/td>\n<\/tr>\n
willard k<\/td>2.1147425268811<\/td>\n<\/tr>\n
crossley k<\/td>2.1147425268811<\/td>\n<\/tr>\n
price k<\/td>2.1147425268811<\/td>\n<\/tr>\n
disposable gloves<\/td>2.1147425268811<\/td>\n<\/tr>\n
american academy of family physicians<\/td>2.1039790110173<\/td>\n<\/tr>\n
macinga d<\/td>2.0597671439071<\/td>\n<\/tr>\n
signs of dehydration<\/td>2.0597671439071<\/td>\n<\/tr>\n
fitts d<\/td>2.0597671439071<\/td>\n<\/tr>\n
number of antibiotics<\/td>2.0597671439071<\/td>\n<\/tr>\n
bakker d<\/td>2.0597671439071<\/td>\n<\/tr>\n
infected persons<\/td>2.0597671439071<\/td>\n<\/tr>\n
drug-resistant bacteria<\/td>2.0597671439071<\/td>\n<\/tr>\n
patient encounter<\/td>2.0597671439071<\/td>\n<\/tr>\n
bad bacteria<\/td>2.0597671439071<\/td>\n<\/tr>\n
narrow-spectrum antibiotics<\/td>2.0597671439071<\/td>\n<\/tr>\n
high-risk persons<\/td>2.0597671439071<\/td>\n<\/tr>\n
antibiotic-resistant bacteria<\/td>2.0597671439071<\/td>\n<\/tr>\n
leopold d<\/td>2.0597671439071<\/td>\n<\/tr>\n
patient populations<\/td>2.0597671439071<\/td>\n<\/tr>\n
patient encounters<\/td>2.0597671439071<\/td>\n<\/tr>\n
lyras d<\/td>2.0597671439071<\/td>\n<\/tr>\n
epidemiologic studies<\/td>2.0597671439071<\/td>\n<\/tr>\n
multinational studies<\/td>2.0597671439071<\/td>\n<\/tr>\n
patient selection<\/td>2.0597671439071<\/td>\n<\/tr>\n
exposure present<\/td>2.0597671439071<\/td>\n<\/tr>\n
roscoe d<\/td>2.0597671439071<\/td>\n<\/tr>\n
national ribotyping-based surveillance scheme<\/td>2.0565711885958<\/td>\n<\/tr>\n
american college of gastroenterology<\/td>2.0396489026555<\/td>\n<\/tr>\n
obvious alternative diagnosis<\/td>2.0396489026555<\/td>\n<\/tr>\n
1.5 mg\/dl<\/td>2<\/td>\n<\/tr>\n
kyne l<\/td>2<\/td>\n<\/tr>\n
ash l<\/td>2<\/td>\n<\/tr>\n
valiquette l<\/td>2<\/td>\n<\/tr>\n
strong evidence<\/td>2<\/td>\n<\/tr>\n
masucci l<\/td>2<\/td>\n<\/tr>\n
kelly cp<\/td>2<\/td>\n<\/tr>\n
mooney l<\/td>2<\/td>\n<\/tr>\n
kelly cr<\/td>2<\/td>\n<\/tr>\n
continued surveillance<\/td>2<\/td>\n<\/tr>\n
multiple recurrences<\/td>2<\/td>\n<\/tr>\n
chiarello l<\/td>2<\/td>\n<\/tr>\n
supporting evidence<\/td>2<\/td>\n<\/tr>\n
cell culture cytotoxicity neutralization assay<\/td>1.9871338585183<\/td>\n<\/tr>\n
u.s. environmental protection agency<\/td>1.9839302766304<\/td>\n<\/tr>\n
lee jt jr<\/td>1.9786024464679<\/td>\n<\/tr>\n
many recommendations<\/td>1.9679896712654<\/td>\n<\/tr>\n
recommended procedure<\/td>1.9679896712654<\/td>\n<\/tr>\n
updated recommendations<\/td>1.9679896712654<\/td>\n<\/tr>\n
many strategies<\/td>1.9679896712654<\/td>\n<\/tr>\n
numerous formulations of probiotics<\/td>1.9559811771959<\/td>\n<\/tr>\n
complete blood count<\/td>1.9559811771959<\/td>\n<\/tr>\n
quality measures<\/td>1.9343364202677<\/td>\n<\/tr>\n
cammarota g<\/td>1.9343364202677<\/td>\n<\/tr>\n
bearman g<\/td>1.9343364202677<\/td>\n<\/tr>\n
chemotherapeutic agents<\/td>1.9343364202677<\/td>\n<\/tr>\n
ianiro g<\/td>1.9343364202677<\/td>\n<\/tr>\n
supportive measures<\/td>1.9343364202677<\/td>\n<\/tr>\n
several naats<\/td>1.9343364202677<\/td>\n<\/tr>\n
alcohol-based handrub<\/td>1.9343364202677<\/td>\n<\/tr>\n
acute-care settings<\/td>1.9343364202677<\/td>\n<\/tr>\n
high morbidity<\/td>1.9343364202677<\/td>\n<\/tr>\n
costamagna g<\/td>1.9343364202677<\/td>\n<\/tr>\n
nonoutbreak settings<\/td>1.9343364202677<\/td>\n<\/tr>\n
several months<\/td>1.9343364202677<\/td>\n<\/tr>\n
antiperistaltic agents<\/td>1.9343364202677<\/td>\n<\/tr>\n
harms of probiotics<\/td>1.9343364202677<\/td>\n<\/tr>\n
dinoi g<\/td>1.9343364202677<\/td>\n<\/tr>\n
relevant measures<\/td>1.9343364202677<\/td>\n<\/tr>\n
cross-over trial<\/td>1.9343364202677<\/td>\n<\/tr>\n
b enzyme immunoassays<\/td>1.9063685859939<\/td>\n<\/tr>\n
new foodborne pathogen<\/td>1.9063685859939<\/td>\n<\/tr>\n
shea long-term-care committee<\/td>1.9063685859939<\/td>\n<\/tr>\n
van dorp sm<\/td>1.9063685859939<\/td>\n<\/tr>\n
alice y. guh<\/td>1.9063685859939<\/td>\n<\/tr>\n
small case series<\/td>1.9063685859939<\/td>\n<\/tr>\n
peritoneal signs<\/td>1.8612097182042<\/td>\n<\/tr>\n
haeck o<\/td>1.8612097182042<\/td>\n<\/tr>\n
intravenous bezlotoxumab<\/td>1.8612097182042<\/td>\n<\/tr>\n
fitzgerald t<\/td>1.8612097182042<\/td>\n<\/tr>\n
brazier js<\/td>1.8612097182042<\/td>\n<\/tr>\n
surawicz cm<\/td>1.8612097182042<\/td>\n<\/tr>\n
schultz me<\/td>1.8612097182042<\/td>\n<\/tr>\n
published trials<\/td>1.8612097182042<\/td>\n<\/tr>\n
steiner t<\/td>1.8612097182042<\/td>\n<\/tr>\n
mulligan me<\/td>1.8612097182042<\/td>\n<\/tr>\n
sitzlar b<\/td>1.8612097182042<\/td>\n<\/tr>\n
disposable gowns<\/td>1.8612097182042<\/td>\n<\/tr>\n
drs. guh<\/td>1.8612097182042<\/td>\n<\/tr>\n
rupp me<\/td>1.8612097182042<\/td>\n<\/tr>\n
toxin-binding polymer<\/td>1.8612097182042<\/td>\n<\/tr>\n
possibility of exposure<\/td>1.8612097182042<\/td>\n<\/tr>\n
current data<\/td>1.8612097182042<\/td>\n<\/tr>\n
concomitant reduction<\/td>1.8612097182042<\/td>\n<\/tr>\n
associated diarrhoea<\/td>1.8612097182042<\/td>\n<\/tr>\n
long-term-care facilities<\/td>1.8612097182042<\/td>\n<\/tr>\n
palda va<\/td>1.8612097182042<\/td>\n<\/tr>\n
delaney ja<\/td>1.8612097182042<\/td>\n<\/tr>\n
guh ay<\/td>1.8612097182042<\/td>\n<\/tr>\n
midtvedt t<\/td>1.8612097182042<\/td>\n<\/tr>\n
delaney cp<\/td>1.8612097182042<\/td>\n<\/tr>\n
signs of peritonitis<\/td>1.8612097182042<\/td>\n<\/tr>\n
potential benefits<\/td>1.8612097182042<\/td>\n<\/tr>\n
lesur o<\/td>1.8612097182042<\/td>\n<\/tr>\n
golubchik t<\/td>1.8612097182042<\/td>\n<\/tr>\n
respiratory infections<\/td>1.8612097182042<\/td>\n<\/tr>\n
management changes<\/td>1.8612097182042<\/td>\n<\/tr>\n
appropriate implementation<\/td>1.8612097182042<\/td>\n<\/tr>\n
baker me<\/td>1.8612097182042<\/td>\n<\/tr>\n
subtotal colectomy<\/td>1.8612097182042<\/td>\n<\/tr>\n
alary me<\/td>1.8612097182042<\/td>\n<\/tr>\n
intravenous immunoglobulins<\/td>1.8612097182042<\/td>\n<\/tr>\n
ann surg<\/td>1.8612097182042<\/td>\n<\/tr>\n
saccharomyces boulardii<\/td>1.8612097182042<\/td>\n<\/tr>\n
same room<\/td>1.8612097182042<\/td>\n<\/tr>\n
birch t<\/td>1.8612097182042<\/td>\n<\/tr>\n
domestic animals<\/td>1.8612097182042<\/td>\n<\/tr>\n
national action plan<\/td>1.8493111942973<\/td>\n<\/tr>\n
van nood e<\/td>1.8171205928321<\/td>\n<\/tr>\n
preeta k. kutty<\/td>1.8171205928321<\/td>\n<\/tr>\n
protective effect of gowns<\/td>1.8171205928321<\/td>\n<\/tr>\n
supplemental enteral feedings<\/td>1.7817974362807<\/td>\n<\/tr>\n
specific immune defects<\/td>1.7817974362807<\/td>\n<\/tr>\n
human monoclonal antibody<\/td>1.7817974362807<\/td>\n<\/tr>\n
current state of knowledge<\/td>1.7817974362807<\/td>\n<\/tr>\n
high-level fluoroquinolone resistance<\/td>1.7817974362807<\/td>\n<\/tr>\n
abdominal distention<\/td>1.7782794100389<\/td>\n<\/tr>\n
lack of improvement<\/td>1.7782794100389<\/td>\n<\/tr>\n
compared fmt<\/td>1.7782794100389<\/td>\n<\/tr>\n
dunn jr<\/td>1.7782794100389<\/td>\n<\/tr>\n
farley mm<\/td>1.7782794100389<\/td>\n<\/tr>\n
sporicidal disinfectant<\/td>1.7782794100389<\/td>\n<\/tr>\n
abdominal pain<\/td>1.7782794100389<\/td>\n<\/tr>\n
significant decrease<\/td>1.7782794100389<\/td>\n<\/tr>\n
anderson jr<\/td>1.7782794100389<\/td>\n<\/tr>\n
gastrointestinal manipulation<\/td>1.7782794100389<\/td>\n<\/tr>\n
gastrointestinal cancer<\/td>1.7782794100389<\/td>\n<\/tr>\n
significant ileus<\/td>1.7782794100389<\/td>\n<\/tr>\n
expected improvement<\/td>1.7782794100389<\/td>\n<\/tr>\n
riggs mm<\/td>1.7782794100389<\/td>\n<\/tr>\n
recommended dosage<\/td>1.7782794100389<\/td>\n<\/tr>\n
autologous fmt<\/td>1.7782794100389<\/td>\n<\/tr>\n
samore mh<\/td>1.7782794100389<\/td>\n<\/tr>\n
duodenal infusion of donor feces<\/td>1.7692284081335<\/td>\n<\/tr>\n
limit of detection<\/td>1.7320508075689<\/td>\n<\/tr>\n
smith mb<\/td>1.7320508075689<\/td>\n<\/tr>\n
limited data<\/td>1.7320508075689<\/td>\n<\/tr>\n
microbial disruption<\/td>1.7320508075689<\/td>\n<\/tr>\n
primary method<\/td>1.7320508075689<\/td>\n<\/tr>\n
colonic perforation<\/td>1.7320508075689<\/td>\n<\/tr>\n
persistent fever<\/td>1.7320508075689<\/td>\n<\/tr>\n
healthy donors<\/td>1.7320508075689<\/td>\n<\/tr>\n
polymerase chain reaction<\/td>1.6983813295649<\/td>\n<\/tr>\n
alcohol fs ability<\/td>1.6983813295649<\/td>\n<\/tr>\n
positive predictive values<\/td>1.6983813295649<\/td>\n<\/tr>\n
toxin-binding anion-exchange resins<\/td>1.6983813295649<\/td>\n<\/tr>\n
enzyme-linked immunosorbent assays<\/td>1.6983813295649<\/td>\n<\/tr>\n
specific classes<\/td>1.6817928305074<\/td>\n<\/tr>\n
mu y<\/td>1.6817928305074<\/td>\n<\/tr>\n
prior recurrences<\/td>1.6817928305074<\/td>\n<\/tr>\n
muganda cp<\/td>1.6817928305074<\/td>\n<\/tr>\n
gordon sm<\/td>1.6817928305074<\/td>\n<\/tr>\n
summers km<\/td>1.6817928305074<\/td>\n<\/tr>\n
moorthi km<\/td>1.6817928305074<\/td>\n<\/tr>\n
significance of findings<\/td>1.6817928305074<\/td>\n<\/tr>\n
golan y<\/td>1.6817928305074<\/td>\n<\/tr>\n
notermans dw<\/td>1.6817928305074<\/td>\n<\/tr>\n
gill ja<\/td>1.6817928305074<\/td>\n<\/tr>\n
coen p<\/td>1.6817928305074<\/td>\n<\/tr>\n
clostridial diarrhoea<\/td>1.6817928305074<\/td>\n<\/tr>\n
nursing homes<\/td>1.6817928305074<\/td>\n<\/tr>\n
reusable equipment<\/td>1.6817928305074<\/td>\n<\/tr>\n
watery stools<\/td>1.6817928305074<\/td>\n<\/tr>\n
loose stools<\/td>1.6817928305074<\/td>\n<\/tr>\n
unformed stools<\/td>1.6817928305074<\/td>\n<\/tr>\n
vos wm<\/td>1.6817928305074<\/td>\n<\/tr>\n
specific syndromes<\/td>1.6817928305074<\/td>\n<\/tr>\n
negative results<\/td>1.6817928305074<\/td>\n<\/tr>\n
holzbauer sm<\/td>1.6817928305074<\/td>\n<\/tr>\n
shanholtzer cj<\/td>1.6817928305074<\/td>\n<\/tr>\n
crook dw<\/td>1.6817928305074<\/td>\n<\/tr>\n
isolation precautions<\/td>1.6817928305074<\/td>\n<\/tr>\n
carter y<\/td>1.6817928305074<\/td>\n<\/tr>\n
tenover fc<\/td>1.6817928305074<\/td>\n<\/tr>\n
eyre dw<\/td>1.6817928305074<\/td>\n<\/tr>\n
common cause<\/td>1.6817928305074<\/td>\n<\/tr>\n
subsequent recurrences<\/td>1.6817928305074<\/td>\n<\/tr>\n
concurrent diagnosis<\/td>1.6817928305074<\/td>\n<\/tr>\n
brassard p<\/td>1.6817928305074<\/td>\n<\/tr>\n
villemure p<\/td>1.6817928305074<\/td>\n<\/tr>\n
hanrahan ja<\/td>1.6817928305074<\/td>\n<\/tr>\n
normal saline<\/td>1.6817928305074<\/td>\n<\/tr>\n
mullane km<\/td>1.6817928305074<\/td>\n<\/tr>\n
first recurrence<\/td>1.6817928305074<\/td>\n<\/tr>\n
weiler md<\/td>1.6817928305074<\/td>\n<\/tr>\n
therapeutic options<\/td>1.6817928305074<\/td>\n<\/tr>\n
prevalence of pcr ribotypes<\/td>1.5874010519682<\/td>\n<\/tr>\n
yellow mucosal plaques<\/td>1.5874010519682<\/td>\n<\/tr>\n
aliment pharmacol ther<\/td>1.5874010519682<\/td>\n<\/tr>\n
whole genome sequencing<\/td>1.5874010519682<\/td>\n<\/tr>\n
modify ii investigators<\/td>1.5874010519682<\/td>\n<\/tr>\n
margaret trexler hessen<\/td>1.5874010519682<\/td>\n<\/tr>\n
mobile genetic elements<\/td>1.5874010519682<\/td>\n<\/tr>\n
moderate adverse events<\/td>1.5874010519682<\/td>\n<\/tr>\n
short-chain fatty acids<\/td>1.5874010519682<\/td>\n<\/tr>\n
killgore ge<\/td>1.5650845800733<\/td>\n<\/tr>\n
johal ss<\/td>1.5650845800733<\/td>\n<\/tr>\n
less-invasive procedure<\/td>1.5650845800733<\/td>\n<\/tr>\n
minimum criteria<\/td>1.5650845800733<\/td>\n<\/tr>\n
microbial balance<\/td>1.5650845800733<\/td>\n<\/tr>\n
healthy person<\/td>1.5650845800733<\/td>\n<\/tr>\n
songer jg<\/td>1.5650845800733<\/td>\n<\/tr>\n
cadnum jl<\/td>1.5650845800733<\/td>\n<\/tr>\n
oughton mt<\/td>1.5650845800733<\/td>\n<\/tr>\n
generalized debility<\/td>1.5650845800733<\/td>\n<\/tr>\n
high-risk drugs<\/td>1.5650845800733<\/td>\n<\/tr>\n
acidic environment<\/td>1.5650845800733<\/td>\n<\/tr>\n
colonic abnormalities<\/td>1.5650845800733<\/td>\n<\/tr>\n
gould lh<\/td>1.5650845800733<\/td>\n<\/tr>\n
general debility<\/td>1.5650845800733<\/td>\n<\/tr>\n
huber ra<\/td>1.5650845800733<\/td>\n<\/tr>\n
lee ch<\/td>1.5650845800733<\/td>\n<\/tr>\n
simor ae<\/td>1.5650845800733<\/td>\n<\/tr>\n
smith z<\/td>1.5650845800733<\/td>\n<\/tr>\n
glatt ae<\/td>1.5650845800733<\/td>\n<\/tr>\n
unrelated donors<\/td>1.5650845800733<\/td>\n<\/tr>\n
primary means<\/td>1.5650845800733<\/td>\n<\/tr>\n
four hospitals<\/td>1.5650845800733<\/td>\n<\/tr>\n
frozen inoculum<\/td>1.5650845800733<\/td>\n<\/tr>\n
bartlett jg<\/td>1.5650845800733<\/td>\n<\/tr>\n
private room<\/td>1.5650845800733<\/td>\n<\/tr>\n
alcohol rub<\/td>1.5650845800733<\/td>\n<\/tr>\n
prespecified criteria<\/td>1.5650845800733<\/td>\n<\/tr>\n
rhinehart e<\/td>1.5650845800733<\/td>\n<\/tr>\n
frozen vs<\/td>1.5650845800733<\/td>\n<\/tr>\n
shah ps<\/td>1.5650845800733<\/td>\n<\/tr>\n
saxton jd<\/td>1.5650845800733<\/td>\n<\/tr>\n
previous version<\/td>1.5650845800733<\/td>\n<\/tr>\n
high-touch surfaces<\/td>1.5650845800733<\/td>\n<\/tr>\n
arch surg<\/td>1.5650845800733<\/td>\n<\/tr>\n
siegel jd<\/td>1.5650845800733<\/td>\n<\/tr>\n
kaplan jl<\/td>1.5650845800733<\/td>\n<\/tr>\n
gould cv<\/td>1.5650845800733<\/td>\n<\/tr>\n
antineoplastic chemotherapy<\/td>1.5650845800733<\/td>\n<\/tr>\n
associated deaths<\/td>1.5650845800733<\/td>\n<\/tr>\n
dunstan f<\/td>1.5650845800733<\/td>\n<\/tr>\n
leukemoid reaction<\/td>1.5650845800733<\/td>\n<\/tr>\n
lamontagne f<\/td>1.5650845800733<\/td>\n<\/tr>\n
hughes ra<\/td>1.5650845800733<\/td>\n<\/tr>\n
acute abdomen<\/td>1.5650845800733<\/td>\n<\/tr>\n
domestic pets<\/td>1.5650845800733<\/td>\n<\/tr>\n
davis mb<\/td>1.5650845800733<\/td>\n<\/tr>\n
intestinal obstruction<\/td>1.5650845800733<\/td>\n<\/tr>\n
exception of cytomegalovirus<\/td>1.4142135623731<\/td>\n<\/tr>\n
jabbar u<\/td>1.4142135623731<\/td>\n<\/tr>\n
bradley sf<\/td>1.4142135623731<\/td>\n<\/tr>\n
knetsch cw<\/td>1.4142135623731<\/td>\n<\/tr>\n
sadowsky mj<\/td>1.4142135623731<\/td>\n<\/tr>\n
early surgery<\/td>1.4142135623731<\/td>\n<\/tr>\n
chitnis as<\/td>1.4142135623731<\/td>\n<\/tr>\n
fourth-generation cephalosporins<\/td>1.4142135623731<\/td>\n<\/tr>\n
madoff rd<\/td>1.4142135623731<\/td>\n<\/tr>\n
bakkanagari sr<\/td>1.4142135623731<\/td>\n<\/tr>\n
independent predictor<\/td>1.4142135623731<\/td>\n<\/tr>\n
mahida yr<\/td>1.4142135623731<\/td>\n<\/tr>\n
colon preparation<\/td>1.4142135623731<\/td>\n<\/tr>\n
careful adherence<\/td>1.4142135623731<\/td>\n<\/tr>\n
browne hp<\/td>1.4142135623731<\/td>\n<\/tr>\n
antiseptic wipes<\/td>1.4142135623731<\/td>\n<\/tr>\n
vandvik po<\/td>1.4142135623731<\/td>\n<\/tr>\n
winston lg<\/td>1.4142135623731<\/td>\n<\/tr>\n
surgical consultation<\/td>1.4142135623731<\/td>\n<\/tr>\n
wilson rg<\/td>1.4142135623731<\/td>\n<\/tr>\n
retail meats<\/td>1.4142135623731<\/td>\n<\/tr>\n
adequate distribution<\/td>1.4142135623731<\/td>\n<\/tr>\n
sethi ak<\/td>1.4142135623731<\/td>\n<\/tr>\n
pig farms<\/td>1.4142135623731<\/td>\n<\/tr>\n
white house<\/td>1.4142135623731<\/td>\n<\/tr>\n
euro surveill<\/td>1.4142135623731<\/td>\n<\/tr>\n
corless jk<\/td>1.4142135623731<\/td>\n<\/tr>\n
mayo clinic<\/td>1.4142135623731<\/td>\n<\/tr>\n
zoetendal eg<\/td>1.4142135623731<\/td>\n<\/tr>\n
short term<\/td>1.4142135623731<\/td>\n<\/tr>\n
iwen pc<\/td>1.4142135623731<\/td>\n<\/tr>\n
asked questions<\/td>1.4142135623731<\/td>\n<\/tr>\n
passive immunotherapy<\/td>1.4142135623731<\/td>\n<\/tr>\n
quan tp<\/td>1.4142135623731<\/td>\n<\/tr>\n
baxter nn<\/td>1.4142135623731<\/td>\n<\/tr>\n
martzen mr<\/td>1.4142135623731<\/td>\n<\/tr>\n
possible sepsis<\/td>1.4142135623731<\/td>\n<\/tr>\n
eckstein ec<\/td>1.4142135623731<\/td>\n<\/tr>\n
end-organ dysfunction<\/td>1.4142135623731<\/td>\n<\/tr>\n
geriatric service<\/td>1.4142135623731<\/td>\n<\/tr>\n
fecal?oral route<\/td>1.4142135623731<\/td>\n<\/tr>\n
debast sb<\/td>1.4142135623731<\/td>\n<\/tr>\n
renal failure<\/td>1.4142135623731<\/td>\n<\/tr>\n
parada jp<\/td>1.4142135623731<\/td>\n<\/tr>\n
post kw<\/td>1.4142135623731<\/td>\n<\/tr>\n
apparent response<\/td>1.4142135623731<\/td>\n<\/tr>\n
goldenberg jz<\/td>1.4142135623731<\/td>\n<\/tr>\n
rothenberger da<\/td>1.4142135623731<\/td>\n<\/tr>\n
bulens sn<\/td>1.4142135623731<\/td>\n<\/tr>\n
nicolle le<\/td>1.4142135623731<\/td>\n<\/tr>\n
acceptable size<\/td>1.4142135623731<\/td>\n<\/tr>\n
special diet<\/td>1.4142135623731<\/td>\n<\/tr>\n
loop ileostomy<\/td>1.4142135623731<\/td>\n<\/tr>\n
strausbaugh lj<\/td>1.4142135623731<\/td>\n<\/tr>\n
single test<\/td>1.4142135623731<\/td>\n<\/tr>\n
zabarsky tf<\/td>1.4142135623731<\/td>\n<\/tr>\n
zar fa<\/td>1.4142135623731<\/td>\n<\/tr>\n
dumyati gk<\/td>1.4142135623731<\/td>\n<\/tr>\n
nonrandomized reports<\/td>1.4142135623731<\/td>\n<\/tr>\n
petrof eo<\/td>1.4142135623731<\/td>\n<\/tr>\n
bliss dz<\/td>1.4142135623731<\/td>\n<\/tr>\n
past outbreaks<\/td>1.4142135623731<\/td>\n<\/tr>\n
dingle ke<\/td>1.4142135623731<\/td>\n<\/tr>\n
research purposes<\/td>1.4142135623731<\/td>\n<\/tr>\n
brownstein re<\/td>1.4142135623731<\/td>\n<\/tr>\n
gut lumen<\/td>1.4142135623731<\/td>\n<\/tr>\n
sanders im<\/td>1.4142135623731<\/td>\n<\/tr>\n
ten years<\/td>1.4142135623731<\/td>\n<\/tr>\n
connor tr<\/td>1.4142135623731<\/td>\n<\/tr>\n
nonpathogenic yeasts<\/td>1.4142135623731<\/td>\n<\/tr>\n
cooper bs<\/td>1.4142135623731<\/td>\n<\/tr>\n
kwok ry<\/td>1.4142135623731<\/td>\n<\/tr>\n
jury la<\/td>1.4142135623731<\/td>\n<\/tr>\n
james pd<\/td>1.4142135623731<\/td>\n<\/tr>\n
available laboratories<\/td>1.4142135623731<\/td>\n<\/tr>\n
important contributor<\/td>1.4142135623731<\/td>\n<\/tr>\n
morgan dj<\/td>1.4142135623731<\/td>\n<\/tr>\n
coffin se<\/td>1.4142135623731<\/td>\n<\/tr>\n
length of stay<\/td>1.4142135623731<\/td>\n<\/tr>\n
irreversible neurotoxicity<\/td>1.4142135623731<\/td>\n<\/tr>\n
absence of laxatives<\/td>1.4142135623731<\/td>\n<\/tr>\n
gessert ce<\/td>1.4142135623731<\/td>\n<\/tr>\n
carroll kc<\/td>1.4142135623731<\/td>\n<\/tr>\n
farrow ka<\/td>1.4142135623731<\/td>\n<\/tr>\n
beldavs zg<\/td>1.4142135623731<\/td>\n<\/tr>\n
naat confirmation<\/td>1.4142135623731<\/td>\n<\/tr>\n
peripartum women<\/td>1.4142135623731<\/td>\n<\/tr>\n
4-log reductions<\/td>1.4142135623731<\/td>\n<\/tr>\n
glutamate dehydrogenase<\/td>1.4142135623731<\/td>\n<\/tr>\n
didelot x<\/td>1.4142135623731<\/td>\n<\/tr>\n
molecular typing<\/td>1.4142135623731<\/td>\n<\/tr>\n
jump rl<\/td>1.4142135623731<\/td>\n<\/tr>\n
belflower rm<\/td>1.4142135623731<\/td>\n<\/tr>\n
tool kit<\/td>1.4142135623731<\/td>\n<\/tr>\n
adkins sh<\/td>1.4142135623731<\/td>\n<\/tr>\n
few days<\/td>1.4142135623731<\/td>\n<\/tr>\n
pretest probability<\/td>1.4142135623731<\/td>\n<\/tr>\n
electrolyte imbalances<\/td>1.4142135623731<\/td>\n<\/tr>\n
banach db<\/td>1.4142135623731<\/td>\n<\/tr>\n
hwang sw<\/td>1.4142135623731<\/td>\n<\/tr>\n
conventional handwashing<\/td>1.4142135623731<\/td>\n<\/tr>\n
poxton ir<\/td>1.4142135623731<\/td>\n<\/tr>\n
li q<\/td>1.4142135623731<\/td>\n<\/tr>\n
tedesco fj<\/td>1.4142135623731<\/td>\n<\/tr>\n
edmonds sl<\/td>1.4142135623731<\/td>\n<\/tr>\n
obuchowski na<\/td>1.4142135623731<\/td>\n<\/tr>\n
gordin fm<\/td>1.4142135623731<\/td>\n<\/tr>\n
organic matter<\/td>1.4142135623731<\/td>\n<\/tr>\n
expert panel<\/td>1.4142135623731<\/td>\n<\/tr>\n
poor outcome<\/td>1.4142135623731<\/td>\n<\/tr>\n
somero ms<\/td>1.4142135623731<\/td>\n<\/tr>\n
professional organizations<\/td>1.4142135623731<\/td>\n<\/tr>\n
region of quebec<\/td>1.4142135623731<\/td>\n<\/tr>\n
sambol sp<\/td>1.4142135623731<\/td>\n<\/tr>\n
51.9 episodes<\/td>1<\/td>\n<\/tr>\n
.0 mg\/dl<\/td>1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":2257,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-2466","page","type-page","status-publish","hentry"],"aioseo_notices":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P9nUTT-DM","jetpack_likes_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/comments?post=2466"}],"version-history":[{"count":1,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2466\/revisions"}],"predecessor-version":[{"id":2467,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2466\/revisions\/2467"}],"up":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2257"}],"wp:attachment":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/media?parent=2466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}